AWH - Allied World Assurance Company Holdings Ltd

AWH Stock Chart

AWH Profile

spira Women's Health Inc., along with its subsidiaries, specializes in the development and commercialization of diagnostic tests tailored for gynecologic diseases within the United States. The company's flagship offerings include OVA1, OVERA, and OVA1plus, designed to assess the risk of ovarian malignancy in women presenting with adnexal masses. Additionally, Aspira Women's Health provides ASPiRA GenetiX, a genetic test aimed at evaluating the susceptibility to gynecologic cancers.

Central to its operations, Aspira Women's Health operates Aspira Synergy, a robust testing platform coupled with a cloud service that facilitates decentralized access to protein biomarker and hereditary genetic testing. The company also owns and manages ASPiRA LABS, a specialized laboratory dedicated to applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and diseases. Looking forward, the company continues to advance its pipeline with products like OVAWatch, EndoCheck, and OVAInherit.

Aspira Women's Health collaborates extensively within the medical community, including partnerships with Baylor Genetics and prestigious institutions such as Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz. Moreover, it has forged a strategic alliance with Quest Diagnostics, Incorporated, to broaden its reach and impact in the diagnostic testing landscape. Founded in 1993 and headquartered in Austin, Texas, the company was formerly known as Vermillion, Inc., before rebranding to Aspira Women's Health Inc. in June 2020.

AWH Revenue Chart

AWH Earnings

Analyst Ratings